We have tracked over 2 funding programs and $0 allocated for Alzheimers Disease Research.
| Recent Funding Opportunity |
|---|
| Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed) (Apply for PAR 19 338) Funding Number: PAR 19 338 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (Apply for PAR 23 081) Funding Number: PAR 23 081 Agency: National Institutes of Health Funding Amount: Case Dependent |
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More